EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine

Amit Kumar Srivastav iD, Manoj Kumar Mishra iD, James W Lillard, Rajesh Singh iD

Pharmaceutics · 24.04.2025 · 17 (5) · 555

DOI: 10.3390/pharmaceutics17050555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 24.04.2025. Verfasst von Amit Kumar Srivastav und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310, USA. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, American Cancer Society, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advancements in pharmacogenomics, artificial intelligence (AI), and CRISPR gene-editing technology are revolutionizing precision medicine by enabling highly individualized therapeutic strategies. Artificial intelligence-driven computational techniques improve biomarker discovery and drug optimization while pharmacogenomics helps to identify genetic polymorphisms affecting medicine metabolism, efficacy, and toxicity. Genetically editing based on CRISPR presents a precise method for changing gene expression and repairing damaging mutations. This review explores the convergence of these three fields to enhance improved precision medicine.

Method

A methodical study of the current literature was performed on the effects of pharmacogenomics on drug response variability, artificial intelligence, and CRISPR in predictive modeling and gene-editing applications.

Results

Driven by artificial intelligence, pharmacogenomics allows clinicians to classify patients and select the appropriate medications depending on their DNA profiles. This reduces the side effect risk and increases the therapeutic efficacy. Precision genetic modifications made feasible by CRISPR technology improve therapy outcomes in oncology, metabolic illnesses, neurological diseases, and other fields. The integration of artificial intelligence streamlines genome-editing applications, lowers off-target effects, and increases CRISPR specificity. Notwithstanding these advances, issues including computational biases, moral dilemmas, and legal constraints still arise.

Conclusions

The synergy of artificial intelligence, pharmacogenomics, and CRISPR alters precision medicine by letting customized therapeutic interventions. Clinically translating, however, hinges on resolving data privacy concerns, assuring equitable access, and strengthening legal systems. Future research should focus on refining CRISPR gene-editing technologies, enhancing AI-driven pharmacogenomics, and developing moral guidelines for applying these tools in individualized medicine going forward.

Schlagwörter

Stichwörter der Autor:innen

CRISPR gene editingartificial intelligencegenetic biomarkerspharmacogenomicsprecision medicine

Autor:innen und Institutionen

  • Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310, USA.
  • Department of Biological Sciences, Alabama State University, Montgomery, AL 36104, USA.
  • Cancer Health Equity Institute, Morehouse School of Medicine, 720 Westview Drive SW, Atlanta, GA 30310-1495, USA.

ORCID-Profile: Amit Kumar Srivastav, Manoj Kumar Mishra, Rajesh Singh

Förderung

  • NCI NIH HHS
  • American Cancer Society
  • NIH HHS
  • Department of Defense
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Srivastav, A. K., Mishra, M. K., Lillard, J. W., & Singh, R. (2025). Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine. Pharmaceutics, 17(5), 555. https://doi.org/10.3390/pharmaceutics17050555

Vancouver

Srivastav AK, Mishra MK, Lillard JW, Singh R. Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine. Pharmaceutics. 2025;17(5):555. doi:10.3390/pharmaceutics17050555

BibTeX
@article{Srivastav2025,
  author = {Srivastav, Amit Kumar and Mishra, Manoj Kumar and Lillard, James W and Singh, Rajesh},
  title = {Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {555},
  doi = {10.3390/pharmaceutics17050555}
}
Kostenlos starten →